ATE244232T1 - (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer - Google Patents

(methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer

Info

Publication number
ATE244232T1
ATE244232T1 AT98912164T AT98912164T ATE244232T1 AT E244232 T1 ATE244232 T1 AT E244232T1 AT 98912164 T AT98912164 T AT 98912164T AT 98912164 T AT98912164 T AT 98912164T AT E244232 T1 ATE244232 T1 AT E244232T1
Authority
AT
Austria
Prior art keywords
furanone
methylsulfonyl
cox
inhibitor
phenyl
Prior art date
Application number
AT98912164T
Other languages
English (en)
Inventor
Yves Leblanc
Patrick Roy
Serge Leger
Erich Grimm
Zhaoyin Wang
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9707488.4A external-priority patent/GB9707488D0/en
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Application granted granted Critical
Publication of ATE244232T1 publication Critical patent/ATE244232T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT98912164T 1997-03-14 1998-03-12 (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer ATE244232T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4079497P 1997-03-14 1997-03-14
GBGB9707488.4A GB9707488D0 (en) 1997-04-14 1997-04-14 (Methylsulfonyl)phenyl-2-(5h)-furones with oxygen link as cox-2 inhibitors
PCT/CA1998/000225 WO1998041516A1 (en) 1997-03-14 1998-03-12 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors

Publications (1)

Publication Number Publication Date
ATE244232T1 true ATE244232T1 (de) 2003-07-15

Family

ID=26311370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98912164T ATE244232T1 (de) 1997-03-14 1998-03-12 (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer

Country Status (7)

Country Link
EP (1) EP0970067B1 (de)
JP (1) JP2001514668A (de)
AT (1) ATE244232T1 (de)
CA (1) CA2283100A1 (de)
DE (1) DE69816047T2 (de)
ES (1) ES2201466T3 (de)
WO (1) WO1998041516A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1124798A4 (de) * 1998-10-27 2002-08-28 Merck & Co Inc Synthese von methylthiophenyl-hydroxyketonen
US6426341B1 (en) * 1999-06-30 2002-07-30 Pfizer Inc. Treatment for diabetic complications
US6555540B1 (en) * 1999-06-30 2003-04-29 Pfizer Inc Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors
US6413965B1 (en) * 1999-06-30 2002-07-02 Pfizer Inc. Compositions and treatment for diabetic complications
PT1090915E (pt) * 1999-10-08 2009-08-03 Merial Sas Forma polimórfica b de 3-(ciclopropilmetoxi)-4-[-4-(metilsulfonil)fenil]-5,5-dimetil-5h-furan-2-ona
FR2799462B1 (fr) 1999-10-08 2004-05-28 Merial Sas Procede de preparation d'inhibiteurs cox-2
US6686390B2 (en) * 2000-05-22 2004-02-03 Dr. Reddy's Laboratories Limited Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them
ES2290157T3 (es) 2000-07-20 2008-02-16 Lauras As Uso de inhibidores de cox-2 como inmunoestimulantes en el tratamiento de vih o sida.
PL1745791T3 (pl) 2003-05-07 2013-11-29 Osteologix As Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu
US9771356B2 (en) 2012-09-21 2017-09-26 Rhode Island Hospital Inhibitors of beta-hydroxylase for treatment of cancer
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0551385A (ja) * 1991-08-12 1993-03-02 Sankyo Co Ltd 多環性アルカロイド
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge
JPH10511089A (ja) * 1994-12-21 1998-10-27 メルク フロスト カナダ インコーポレーテツド Ｃｏｘ−２阻害剤としてのジアリール−２−（５ｈ）−フラノン
UA57002C2 (uk) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування
CA2234642C (en) * 1995-10-30 2005-07-26 Merck Frosst Canada Inc. 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
DE69702182T2 (de) * 1996-02-01 2001-03-01 Merck Frosst Canada & Co., Halifax Alkylierte styrole als prodrugs zu cox-2-inhibitoren
HRP970289A2 (en) * 1996-05-31 1998-04-30 Merck & Co Inc Process for preparing phenyl heterocycles useful as cox-2 inhibitors

Also Published As

Publication number Publication date
ES2201466T3 (es) 2004-03-16
EP0970067B1 (de) 2003-07-02
DE69816047T2 (de) 2004-04-22
EP0970067A1 (de) 2000-01-12
JP2001514668A (ja) 2001-09-11
DE69816047D1 (en) 2003-08-07
WO1998041516A1 (en) 1998-09-24
CA2283100A1 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
ATE229515T1 (de) (methylsulfonyl)phenyl-2-(5h)-furanone als cox-2 inhibitoren
ATE212343T1 (de) 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren
ATE165825T1 (de) Phenyl heterocyclen als cyclooxygenase-2 inhibitoren
ATE244232T1 (de) (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer
DE69702182D1 (de) Alkylierte styrole als prodrugs zu cox-2-inhibitoren
ATE223376T1 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
DE69703791D1 (de) Diphenylstibene als prodrugs zu cox-2-inhibitoren
MY119407A (en) 3-phenyl-4-(4(methylsulfonyl)phenyl)-2-(5h)-furanone as a cox-2 inhibitor.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties